- Home
- STRO vs SKLZ Comparison
STRO vs SKLZ Comparison
Compare STRO & SKLZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- SKLZ
- Stock Information
- Founded
- STRO 2003
- SKLZ 2012
- Country
- STRO United States
- SKLZ United States
- Employees
- STRO N/A
- SKLZ N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- SKLZ EDP Services
- Sector
- STRO Health Care
- SKLZ Technology
- Exchange
- STRO Nasdaq
- SKLZ Nasdaq
- Market Cap
- STRO 77.7M
- SKLZ 80.3M
- IPO Year
- STRO 2018
- SKLZ N/A
- Fundamental
- Price
- STRO $0.80
- SKLZ $6.30
- Analyst Decision
- STRO Hold
- SKLZ Buy
- Analyst Count
- STRO 7
- SKLZ 2
- Target Price
- STRO $3.97
- SKLZ $10.75
- AVG Volume (30 Days)
- STRO 833.9K
- SKLZ 48.4K
- Earning Date
- STRO 08-12-2025
- SKLZ 07-31-2025
- Dividend Yield
- STRO N/A
- SKLZ N/A
- EPS Growth
- STRO N/A
- SKLZ N/A
- EPS
- STRO N/A
- SKLZ N/A
- Revenue
- STRO $66,434,000.00
- SKLZ $92,644,000.00
- Revenue This Year
- STRO N/A
- SKLZ $0.20
- Revenue Next Year
- STRO N/A
- SKLZ $14.10
- P/E Ratio
- STRO N/A
- SKLZ N/A
- Revenue Growth
- STRO N/A
- SKLZ N/A
- 52 Week Low
- STRO $0.52
- SKLZ $3.54
- 52 Week High
- STRO $5.17
- SKLZ $7.31
- Technical
- Relative Strength Index (RSI)
- STRO 46.11
- SKLZ 59.83
- Support Level
- STRO $0.76
- SKLZ $6.07
- Resistance Level
- STRO $0.94
- SKLZ $6.39
- Average True Range (ATR)
- STRO 0.07
- SKLZ 0.16
- MACD
- STRO -0.01
- SKLZ -0.05
- Stochastic Oscillator
- STRO 29.11
- SKLZ 77.54
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About SKLZ Skillz Inc.
Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.